Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – The benefit of adding inhaled corticosteroids to long-acting beta-2 agonists for treating chronic obstructive pulmonary disease (COPD) is limited, and furthermore, it’s accompanied…
NEW YORK (Reuters Health) – In patients receiving first-line treatment for metastatic colon cancer, planned complete discontinuation of chemotherapy had a negative impact on duration of disease control…
Federal law enforcement officials have kicked it up a notch when it comes to investigating potentially illegal business arrangements between doctors and hospitals. Over the past two months,…
Listen to a panel of three physicians who provide various perspectives on deep-vein thrombosis (DVT) prophylaxis from a clinical roundtable held on July 13, 2009 during the XXII…
NEW YORK (Reuters Health) – For patients with chronic obstructive pulmonary disease (COPD), the combination of budesonide/formoterol with tiotropium is more effective than tiotropium alone. The triple therapy…
NEW YORK (Reuters Health) – In a phase III trial in women with HER2/hormone receptor-copositive metastatic breast cancer, the combination of trastuzumab plus anastrozole improved outcomes compared to…
NEW YORK (Reuters Health) – Prospective ECG-triggering during computed tomography (CT) scanning of the heart can substantially reduce patients’ exposure to radiation while maintaining imaging accuracy close to…
NEW YORK (Reuters Health) – Opioid analgesics should not be used in elderly patients with osteoarthritis even if their pain is severe, because the associated risks are so…
